Ravali A. Reddy

ORCID: 0009-0004-0336-8801
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Minimally Invasive Surgical Techniques
  • Endometrial and Cervical Cancer Treatments
  • Palliative Care and End-of-Life Issues
  • Medical Education and Admissions
  • Radiomics and Machine Learning in Medical Imaging
  • Diversity and Career in Medicine
  • Sex and Gender in Healthcare
  • Cancer survivorship and care
  • Cancer Genomics and Diagnostics
  • Pituitary Gland Disorders and Treatments
  • Pelvic floor disorders treatments
  • Appendicitis Diagnosis and Management
  • Surgical Simulation and Training
  • Nonmelanoma Skin Cancer Studies
  • Glioma Diagnosis and Treatment
  • Angiogenesis and VEGF in Cancer
  • Medical and Biological Ozone Research
  • Anorectal Disease Treatments and Outcomes
  • Pleural and Pulmonary Diseases
  • Telomeres, Telomerase, and Senescence
  • Lymphoma Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Maternal and Perinatal Health Interventions
  • Colorectal and Anal Carcinomas

Stanford University
2021-2024

University of Kansas
2024

Palo Alto University
2023

University of Kansas Medical Center
2023

University of Southern California
2020-2022

Stanford Cancer Institute
2022

Macquarie University
2016

UNSW Sydney
2016

This case series discusses a human papilloma virus (HPV)–related neovaginal squamous cell carcinoma in transgender woman and the need for formal gynecologic screening recommendations.

10.1001/jamanetworkopen.2024.2537 article EN cc-by-nc-nd JAMA Network Open 2024-03-15

Advanced mixed epithelial endometrial carcinomas are rare high-grade cancers with a poor prognosis. A clear cell component infers relative chemotherapy insensitivity, likely further increased by p53 wild type status and MMR deficiency. PD-1 inhibition for deficient has been recently added to first-line adjuvant treatment in combination platinum-based chemotherapy. Information on de-escalation of alone without is sparse.

10.1159/000540357 article EN cc-by-nc Case Reports in Oncology 2024-08-05

5570 Background: The predicted incidence and incidence-based mortality (IBM) of ovarian cancer (OC) in 2023 is lower than prior years. OC encompasses a range heterogeneous cancers with subtypes categorized on histology site origin. Given differences survival treatment paradigms, we aim to characterize trends IBM based origin determine what factors are responsible for the decline. Methods: Patients from 2000-2019 were identified US Surveillance, Epidemiology, End Results 17 registry database....

10.1200/jco.2023.41.16_suppl.5570 article EN Journal of Clinical Oncology 2023-06-01

Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer, melanoma, and head neck cancer. No published studies exist the use of this endometrial The primary objective was to determine detection rate bilateral SLNs cancer with concurrent technetium ICG. An open-label, single cohort, prospective feasibility study conducted participants receiving preoperative cervical injections followed by...

10.1016/j.gore.2022.101054 article EN cc-by-nc-nd Gynecologic Oncology Reports 2022-07-30

PurposeThe purposes of this study were to systematically review the literature and provide a detailed summary current treatments outcomes for arthrofibrosis following knee arthroscopy anterior cruciate ligament reconstruction (ACLR) compare treatment strategies in pediatric adult populations.MethodsA systematic was performed March 2022 using PubMed, EMBASE, Cochrane Library Databases per PRISMA. Search terms consisted variations following: ("arthrofibrosis" OR "stiffness" "stiff"...

10.1016/j.asmr.2024.100896 article EN cc-by-nc-nd Arthroscopy Sports Medicine and Rehabilitation 2024-02-02

The frequency of cervical insufficiency differs among the major racial and ethnic groups, with limited data specific to Asian American Native Hawaiian/Pacific Islander (AANHPI) subpopulations. We assessed diagnoses related outcomes across 10 including disaggregated AANHPI subgroups, in a large population-based cohort.

10.1089/jwh.2024.0088 article EN Journal of Women s Health 2024-06-26

<title>Abstract</title> Objective To assess and compare the surgical outcomes of robotic-assisted single-site hysterectomy (SSH) multi-site (MSH). Design: A retrospective cohort study from a single academic health care system. Results From October 2013 to June 2022, 127 SSH 445 MSH were performed. 78% patients had normal or overweight BMI compared 49% (p &lt; 0.001). 37% preoperative cancer diagnosis 66% There no differences in average number prior abdominal surgeries = 0.6). The median...

10.21203/rs.3.rs-4786470/v1 preprint EN cc-by Research Square (Research Square) 2024-08-20

Objective To examine women’s journeys with gynecologic cancer from before diagnosis through death and identify elements of their healthcare experience that warrant improvement. Methods This exploratory study used longitudinal progress notes data a multispecialty practice in Northern California. The sample included women stage IV gynecological diagnosed after 2011 who died 2018. Available prior to were qualitatively analyzed. Results We identified 32 women, (median age 61 years) mostly...

10.1177/10499091211064242 article EN American Journal of Hospice and Palliative Medicine® 2021-12-24

Background: Radia on-induced molecular changes on the endothelial surface of brain arteriovenous malforma ons (AVM) may be used as markers for specific vascular targe ng agents.In this study, we examined level expression platelet cell adhesion molecule-1 (PECAM-1) a)er radia treatment, with aim PECAM-1 AVM endothelium prothrombo c agents to selec vely occlude vessels.Materials and Methods: Mouse cerebral cells (bEnd.3)were irradiated 5, 15, or 25 Gy.Real-me quan ta ve polymerase chain reac...

10.18869/acadpub.ijrr.14.3.181 article EN Internatuinal Journal of Radiation Research 2016-07-01

Robotic-assisted minimally invasive surgery is considered safe and effective in gynecologic oncology. While traditional multi-site robotic remains the standard, single-site often thought to have additional benefits related cos-mesis, length of hospital stays, other perioperative outcomes. However, comparison studies between two surgical approaches are lacking. The purpose this study assess outcomes robotic-assisted hysterectomy (SSH) as compared (MSH). Patients who underwent SSH MSH from...

10.1016/s2352-5789(23)00291-6 article EN cc-by-nc-nd Gynecologic Oncology Reports 2023-08-01

The predicted incidence and incidence-based mortality (IBM) of ovarian cancer (OC) in 2023 is lower than prior years. OC encompasses a range heterogeneous cancers with subtypes categorized on histology site origin. Given differences survival treatment paradigms, we aim to characterize trends IBM based origin determine what factors are responsible for the decline. Download : high-res image (270KB)Download full-size Patients from 2000–2019 were identified US Surveillance, Epidemiology, End...

10.1016/s2352-5789(23)00253-9 article EN cc-by-nc-nd Gynecologic Oncology Reports 2023-08-01

10572 Background: To evaluate the characteristics and trends amongst patients with neuroendocrine tumors in United States. Methods: Data was obtained from States Cancer Statistics database 2001 to 2018. SEER*Stat 8.3.9.2 Joinpoint regression program 4.9.0.0 were used calculate of these cancers per 100,000. The age-adjusted incidences determined based on standard population 2000. Results: Of 392,412 tumors, 53.1% identified women 46.9% men. White, Black, Hispanic, Asian/Pacific Islander...

10.1200/jco.2022.40.16_suppl.10572 article EN Journal of Clinical Oncology 2022-06-01

<h3>Objectives</h3> Many individuals with gynecologic malignancies suffer symptoms related to malignant pleural effusions that improve drainage. The objective of this study is review a single institution's experience fluid drainage catheter placement in these patients. <h3>Methods</h3> Adult patients confirmed malignancy who underwent from 2010–2020 were identified, and clinical data was extracted for analysis. <h3>Results</h3> Chart identified 63 patients, the majority whom diagnosed...

10.1136/ijgc-2022-igcs.489 article EN E-Posters 2022-12-01
Coming Soon ...